MANSFIELD, MA – November 18, 2024 – Mansfield Bio-Incubator proudly announces the Second Mansfield Pitch Competition line-up, offering $80,000 in prizes. The competition is set to take place on December 5, 2024.
The event will feature 11 companies, all members of Mansfield Bio-Incubator, across various sectors:
Therapeutics:
· Neuronity Therapeutics – Revolutionizing neurological disorder treatment by restoring the immune system in the aging brain.
· PhagePro – Solving global health disparities by harnessing the therapeutic potential of phages.
· Otrera Medical – Pioneering treatment for female sexual dysfunction caused by anti-depressants.
· Pending AI – Advancing medicine design with scalable AI and quantum mechanics.
· Trivoke Therapeutics – Harnessing innate and adaptive immunity for immediate tumor control and lasting cancer defense.
· Alnivo Therapeutics – Unlocking Heat Shock Protein 70 potential for tissue regeneration and repair.
Diagnostics:
· Aged Diagnostics – Delivering the first accurate blood test for liver disease.
· Emitech – Revolutionizing opioid testing with a supremely convenient, sensitive, and cost-effective method.
· Stapgen – Pioneering the early detection and prevention of Type 2 Diabetes.
Advanced Materials for Healthcare
· Unsmudgeable – Fingerprint-fading eyewear coating for a lifetime of clear vision.
Functional Foods:
· UpLevel Foods – Preventing common chronic diseases with patented dietary breakthroughs.
Six competitors are graduates of the Mansfield Mentoring Program, which provides tailored guidance and support to member companies across all areas of expertise. This program exemplifies the benefits of membership at Mansfield Bio-Incubator, equipping startups with the tools and knowledge they need to succeed in the competitive life sciences industry.
“The breadth of disciplines represented in this competition, combined with the international reach of the participating companies, including those from as far as Australia, showcases the successful growth of our life science ecosystem,” said Russ Yukhananov, President of Mansfield Bio-Incubator. “The event provides a unique platform for emerging companies to gain exposure, expand their networks, receive mentorship, and secure funding to advance their groundbreaking solutions.”
For more information, contact Alex Shlyankevich, Director of Investments, at alexsh@bioinc.org.
---
About Mansfield Bio-Incubator Through its ecosystem activities, Mansfield Bio-Incubator provides comprehensive support to early-stage life science companies, including mentoring programs, pitch competitions, networking opportunities, investor exposure, MassBio/MassMEDIC memberships, and state-of-the-art laboratory and office space. Its mission is to foster innovation in healthcare by helping startups navigate growth and development challenges.
For media inquiries, please contact: info@bioinc.org
Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048